/KASE, December 8, 2017/ - Chimpharm (Shymkent), whose shares are officially listed
on Kazakhstan Stock Exchange (KASE), has in an official letter informed KASE of
concluding a major transaction.
Said information is available on KASE website (in Kazakh and Russian) -
http://www.kase.kz/files/emitters/CHFM/chfm_big_deal_051217_1904.pdf
[2017-12-08]